Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Primary Breast Cancer
Interventions: DRUG: paclitaxel/anthracycline
Sponsor: Tao OUYANG
Collaborators: Beijing Municipal Science & Technology Commission|Peking Union Medical College Hospital|Chinese Academy of Medical Sciences|Peking University First Hospital|Peking University People's Hospital|Beijing Chao Yang Hospital|307 Hospital of PLA